Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer

PURPOSE: Valid determination of HER2 status is a prerequisite to establish an adequate treatment strategy for breast cancer patients, regardless of the disease stage. The goal of this study was to examine the feasibility of the newly developed silver-enhanced in situ hybridization (SISH) technique a...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kyeongmee, Han, Sehwan, Kim, Jung-Yeon, Kim, Hyun-Jung, Kwon, Ji Eun, Gwak, Geumhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268923/
https://www.ncbi.nlm.nih.gov/pubmed/22323913
http://dx.doi.org/10.4048/jbc.2011.14.4.276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268923/
https://www.ncbi.nlm.nih.gov/pubmed/22323913
http://dx.doi.org/10.4048/jbc.2011.14.4.276

Ejemplares similares